AstraZeneca (GB:AZN) has released an update. AstraZeneca PLC has announced its total issued share capital with voting rights stands at 1,550,303,887 ordinary shares as of October 31, 2024. This ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
AstraZeneca disclosed Wednesday that Leon Wang, a high-ranking executive who oversees international operations and is also president of its subsidiary in China, is under investigation by Chinese ...
(Reuters) - AstraZeneca said on Monday it would pay up to $1.9 billion to CSPC Pharmaceutical Group Ltd in an exclusive ...
Covid vaccine compensation could be given to thousands left 'disabled' by the AstraZeneca jab, it has emerged. Health Secretary Wes Streeting is understood to be considering plans to set up a ...
Oct 7 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Monday it would pay up to $1.92 billion to CSPC Pharmaceutical Group Ltd (1093.HK), opens new tab in an exclusive licence agreement to ...
AstraZeneca’s (AZN) Fasenra has been approved in the European Union, EU, as an add-on treatment for adult patients with relapsing or refractory eosinophilic granulomatosis with polyangiitis ...
AstraZeneca’s China president is under investigation in mainland China, the drug company said on Wednesday. Leon Wang was described as cooperating “with an ongoing investigation”, the ...
AstraZeneca will pay CSPC $100 million upfront, with potential for up to $1.92 billion in milestone payments. Airsupra Phase 3b trial shows significant reduction in severe asthma exacerbations ...
AstraZeneca, the UK’s largest drugmaker valued at $140bn, has reportedly contacted Gilead Sciences, an American biopharmaceutical company with a market value of approximately $96bn, regarding a ...
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is, so far, rather ...
BEIJING—An investigation involving a top executive at drugmaker AstraZeneca AZN-0.18%decrease; red down pointing triangle is the latest to rattle foreign companies in China, where a series of ...